Merck KGaA Acquires Bioscience Company in India

Tue Oct 13, 2009 1:30am EDT

* Reuters is not responsible for the content in this press release.

DARMSTADT, Germany & BANGALORE, India--(Business Wire)--
Merck KGaA announced today the acquisition of Bangalore Genei (India) Private
Ltd. (BGIP) by its wholly owned subsidiary in India, Merck Specialities Private
Ltd., from the Sanmar Group. By combining BGIP's activities with Merck's
existing bioscience business, Merck will become one of the leading bioscience
companies in India. 

BGIP is located in Bangalore and specializes in the development, production,
marketing and sales of products for proteomic and genomic research. With more
than 100 employees, the company generated total revenues of INR 202m (€ 3.0
million) in fiscal year 2008/09. 

Christina Shasserre, Global Head of Merck's bioscience business, commented:
"BGIP`s leadership in the Indian academic market, a segment with high growth
potential, will ideally complement our existing customer base. BGIP`s product
portfolio comprises a wide range of bioscience products, which are tailored to
the needs of the domestic market in India." 

About Merck Laboratory Chemicals

Merck is one of the world`s leading suppliers of laboratory chemicals to
research, teaching and industrial establishments, offering an extensive range of
products suitable for analytical chromatography, microbiology, food testing,
environmental analysis and pharmaceutical research. It also produces reagents
for analytical and general applications as well as solvents, salts, acids,
alkalis and organic chemicals. Merck caters a wide variety of laboratory
requirements, providing its customers with specific solutions that allow them to
operate their laboratories safely and efficiently. More information about the
range of products offered by Merck can be found at

About Merck

Merck is a global pharmaceutical and chemical company with total revenues of €
7.6 billion in 2008, a history that began in 1668, and a future shaped by
approximately 33,000 employees in 60 countries. Its success is characterized by
innovations from entrepreneurial employees. Merck's operating activities come
under the umbrella of Merck KGaA, in which the Merck family holds an
approximately 70% interest and free shareholders own the remaining approximately
30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an
independent company ever since.

Merck KGaA
Steffen Grimminger, +49-6151-72-7317 

Copyright Business Wire 2009

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.